Compared to postoperative chemotherapy combined with radiotherapy, preoperative chemotherapy combined with radiotherapy shows higher sphincter preservation rate and lower local recurrence rate in locally advanced rectal cancer. The purpose of this study is to evaluate the response and prognosis of intraarterial chemoembolization and intravenous infusion chemotherapy in patients with rectal T3-T4 and/or N+ rectal cancer before operation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
204
Daping Hospital, Third Military Medical University
Chongqing, Chongqing Municipality, China
RECRUITINGChongqing Zhongshan Hospital
Chongqing, Chongqing Municipality, China
RECRUITINGJiangjin Central Hospital
Chongqing, Chongqing Municipality, China
RECRUITINGPathological Complete Response (pCR)
Pathological complete response (pCR) was determined on tumor resection specimens after completion of neoadjuvant therapy, and was defined as no evidence of residual invasive and ductal disease in the rectum and lymph nodes
Time frame: pathologic examination following surgery, at aproximately 9-10 weeks or after preoperative intraarterial chemoembolization plus radiotherpy
the Sphincter Preservation Rate
Time frame: 3 month
Disease-free survival
Time frame: Following surgery, 5 years
Overall Survival
Time frame: the first day of treatment to death or last survival confirm date; assesed up to 5 years
Down Staging Rate
Time frame: Until surgery at 8-9 weeks post chemoradiation plus radiation (which is 4-5 weeks)
Number of Participants with Adverse Events
Time frame: Until surgery at 8-9 weeks post chemoradiation plus radiation (which is 4-5 weeks)
Number of Postoperative Complication
Time frame: Until surgery at 8-9 weeks post chemoradiation plus radiation (which is 4-5 weeks)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.